Fingerprint
Dive into the research topics of 'Phase i study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically